Showing results (761-770 of 1,922) with videos related to
Sort By:
Pageof 193
Cancer|August 16, 2008
The prognostic impact of dedifferentiation in retroperitoneal liposarcoma: a series of surgically treated patients at a single institutionChiara Mussi, Paola Collini, Rosalba Miceli, et al.The Journal of Biological Chemistry|April 4, 2003
Selective inhibition of class switching to IgG and IgE by recruitment of the HoxC4 and Oct-1 homeodomain proteins and Ku70/Ku86 to newly identified ATTT cis-elementsAndrás Schaffer, Edmund C Kim, Xiaoping Wu, et al.Cerebellum (London, England)|October 7, 2011
Infantile childhood onset of spinocerebellar ataxia type 2Roberto Di Fabio, Filippo Santorelli, Enrico Bertini, et al.Annals of Surgical Oncology|July 28, 2011
Surgical technique, morbidity, and outcome of primary retroperitoneal sarcoma involving inferior vena cavaMarco Fiore, Chiara Colombo, Piermarco Locati, et al.Cancer|October 6, 2005
Diffuse malignant mesothelioma of the peritoneum: a clinicopathological study of 35 patients treated locoregionally at a single institutionDaisuke Nonaka, Shigeki Kusamura, Dario Baratti, et al.Journal of Clinical Medicine|April 12, 2025
Outcome Analysis of Pre-Emptive Embolization of the Collateral Branches of the Abdominal Aorta During Standard Infrarenal Endovascular Aortic RepairRaffaello Bellosta, Francesco D'Amario, Luca Luzzani, et al.Journal of Dairy Science|March 26, 2025
Effects of animal rennet, fermentation-produced chymosin, and microbial coagulants on bovine milk coagulation propertiesGiorgia Stocco, Dario Casali, Andrea Summer, et al.Annals of Biomedical Engineering|April 10, 2012
Ex vivo gene delivery to hepatocytes: techniques, challenges, and underlying mechanismsShan Gao, Erkin Seker, Monica Casali, et al.International Journal of Cardiology|June 4, 2013
Indexed maximal left atrial volume predicts response to cardiac resynchronization therapyLuca Rossi, Alessandro Malagoli, Massimo Piepoli, et al.Journal of the National Cancer Institute|March 21, 1990
Pharmacology and clinical toxicity of 4'-iodo-4'-deoxydoxorubicin: an example of successful application of pharmacokinetics to dose escalation in phase I trialsL Gianni, L Viganò, A Surbone, et al.Pageof 193